Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Bahnbrechende KI-Lösung "Ohne Nadelstiche" als Ersatz für herkömmliche Bluttests "unlocked"?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A42ADK | ISIN: US47010C8626 | Ticker-Symbol: 1JA1
NASDAQ
13.05.26 | 20:07
3,370 US-Dollar
+3,69 % +0,120
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
JAGUAR HEALTH INC Chart 1 Jahr
5-Tage-Chart
JAGUAR HEALTH INC 5-Tage-Chart

Aktuelle News zur JAGUAR HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrNASDAQ gewährt Jaguar Health Aufschub bei Mindestkursanforderung6
FrJaguar Health gets extension to meet Nasdaq bid price rule4
FrJaguar Health, Inc.: Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule322SAN FRANCISCO, CA / ACCESS Newswire / May 8, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today provided an update on the status of the Company's listing on The Nasdaq Stock...
► Artikel lesen
06.05.Jaguar Health, Inc.: Jaguar Health Announces Preliminary Discussion with FDA to Evaluate Breakthrough Therapy Designation for Crofelemer for Treatment of Microvillus Inclusion Disease264Pediatric patients with Intestinal Failure (IF) due to MVID, an ultrarare congenital disorder with lethal natural history, that has no available therapies and needs lifelong total Parenteral Support...
► Artikel lesen
04.05.Jaguar Health to launch Neonorm Dog digestive health product4
04.05.Jaguar Health lanciert Verdauungspräparat für Hunde trotz massiver Kursverluste6
JAGUAR HEALTH Aktie jetzt für 0€ handeln
04.05.Jaguar Health, Inc.: Jaguar Health Expands Neonorm Franchise with Introduction of Neonorm Dog for Companion Animal Gut Health232Neonorm Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool formation, gut hydration...
► Artikel lesen
04.05.Jaguar Health, Inc. - 8-K, Current Report3
30.04.XFRA 1JA1: AUSSETZUNG/SUSPENSION227DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILJAGUAR HEALTH 26...
► Artikel lesen
30.04.XFRA NEW INSTRUMENTS AVAILABLE ON 30.04.2026306The following instruments on XETRA do have their first trading 30.04.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 30.04.2026 Aktien 1 ID1000115702 Bank Pembangunan Daerah...
► Artikel lesen
29.04.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 29.04.2026413The following instruments on Boerse Frankfurt do have their last trading day on 29.04.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 29.04.2026ISIN NameCA73689L2075 PORTOFINO...
► Artikel lesen
29.04.XFRA ISIN CHANGE333Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA7481197084 Quebec Nickel Corp. 29.04.2026 CA0515341059 Aurbis Resources Corp. 30.04.2026 Tausch 1:1CA89620A5061 Trigon...
► Artikel lesen
29.04.Jaguar Health, Inc.: Jaguar Health Announces Statistically Significant Results from Effectiveness Trial of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea in Dogs2.935Company Advances Towards Full FDA Approval of Crofelemer for Chemotherapy-Induced Diarrhea SAN FRANCISCO, CA / ACCESS Newswire / April 29, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced...
► Artikel lesen
27.04.Jaguar Health erhält Nasdaq-Fristverlängerung und kündigt Aktienzusammenlegung im Verhältnis 1:35 an30
27.04.Jaguar Health receives Nasdaq extension, plans 1-for-35 reverse split8
27.04.Jaguar Health, Inc.: Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split1.611Reverse split approved at April 2026 Special Meeting of StockholdersShares of Jaguar Health common stock to begin trading on split-adjusted basis on April 30, 2026 SAN FRANCISCO, CA / ACCESS Newswire...
► Artikel lesen
24.04.Jaguar Health, Inc.: Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition145Intestinal Failure (IF) occurs in patients with an ultrarare congenital enteropathy due to microvillus inclusion disease (MVID) and/or short bowel syndrome (SBS)Jaguar has received orphan drug designations...
► Artikel lesen
21.04.Jaguar Health, Inc. - 8-K, Current Report-
20.04.Jaguar Health, Inc.: Jaguar Health Reports Approval of All Proposals at April 2026 Special Meeting of Stockholders2.148SAN FRANCISCO, CA / ACCESS Newswire / April 20, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced the voting results of the Company's Special Meeting of Stockholders...
► Artikel lesen
13.04.Jaguar Health, Inc.: Artificial Intelligence Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure Programs281Global Market for Short Bowel Syndrome, Including Intestinal Failure (IF), Estimated to Reach $8.0 Billion by 20331AI data mining of real world clinical and symptom manifestation is beneficial in the...
► Artikel lesen
Weiter >>
102 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1